• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较那他霉素和伏立康唑经兔眼局部给药后的眼内穿透和药代动力学。

Comparison of the Ocular Penetration and Pharmacokinetics Between Natamycin and Voriconazole After Topical Instillation in Rabbits.

机构信息

Shenyang Xingqi Pharmaceutical Co., Ltd., Shenyang, People's Republic of China .

出版信息

J Ocul Pharmacol Ther. 2018 Jul/Aug;34(6):460-467. doi: 10.1089/jop.2017.0139. Epub 2018 May 24.

DOI:10.1089/jop.2017.0139
PMID:29792548
Abstract

PURPOSE

To investigate the ocular penetration of natamycin (NAT) and voriconazole (VRC) after topical instillation in New Zealand white rabbits using simplified liquid chromatography-tandem mass spectrometry (LC-MS/MS) and high-performance liquid chromatography.

METHODS

Seventy-eight healthy rabbits were randomly divided into 3 groups. In the first 2 groups, 72 rabbits were used for single-dose testing (36 for NAT, 36 for VRC), in which 50 μL of 5.0% NAT or 1.0% VRC was instilled into the rabbits' left eyes. In the 3rd group, 6 rabbits were used for repeated-dose testing in which 50 μL of 5.0% NAT was instilled into their left eyes 12 times (once per hour) during the daytime. These animals were sacrificed immediately to collect their aqueous humors and corneas.

RESULTS

After a single topical instillation, the highest concentrations in the cornea and aqueous humor for VRC were 34.1 μg/g and 14.7 μg/mL, respectively. The permeability ratios of aqueous/cornea were from 0.1 to 1.26. The highest concentrations in cornea and aqueous humor for NAT were 299.3 ng/g and 27.1 ng/mL, respectively. The permeability ratios of aqueous/cornea were from 0.02 to 0.23. In the repeated-dose group, the NAT concentrations in the cornea and aqueous humor were 10,569 ng/g and 54.4 ng/mL, respectively. The permeability ratio was as low as 0.0051.

CONCLUSION

The better corneal penetration of VRC suggests that it is more suitable for deep corneal fungal infections than NAT via topical ocular administration.

摘要

目的

使用简化液相色谱-串联质谱(LC-MS/MS)和高效液相色谱法研究新西兰白兔局部滴注那他霉素(NAT)和伏立康唑(VRC)后的眼部穿透率。

方法

78 只健康兔随机分为 3 组。前 2 组中,36 只用于单剂量试验(NAT 组 36 只,VRC 组 36 只),其中 50 μL 5.0% NAT 或 1.0% VRC 滴注入兔子左眼。第 3 组中,6 只用于重复剂量试验,在白天期间,12 次(每小时 1 次)向其左眼滴注 50 μL 5.0% NAT。这些动物被立即处死以收集房水和角膜。

结果

单次局部滴注后,VRC 在角膜和房水中的最高浓度分别为 34.1μg/g 和 14.7μg/mL。水/角膜的渗透比为 0.1 至 1.26。NAT 在角膜和房水中的最高浓度分别为 299.3ng/g 和 27.1ng/mL。水/角膜的渗透比为 0.02 至 0.23。在重复剂量组中,NAT 在角膜和房水中的浓度分别为 10569ng/g 和 54.4ng/mL。渗透比低至 0.0051。

结论

VRC 更好的角膜穿透性表明,与局部眼部给药相比,它更适合深部角膜真菌感染。

相似文献

1
Comparison of the Ocular Penetration and Pharmacokinetics Between Natamycin and Voriconazole After Topical Instillation in Rabbits.比较那他霉素和伏立康唑经兔眼局部给药后的眼内穿透和药代动力学。
J Ocul Pharmacol Ther. 2018 Jul/Aug;34(6):460-467. doi: 10.1089/jop.2017.0139. Epub 2018 May 24.
2
Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.比较局部应用 1%伏立康唑后未刮除和刮除角膜上皮组房水和玻璃体内伏立康唑浓度。
Curr Eye Res. 2010 Jul;35(7):573-9. doi: 10.3109/02713681003760135.
3
Pharmacokinetics of Sirolimus Eye Drops Following Topical Ocular Administration in Rabbits.兔眼局部滴用西罗莫司滴眼液的药代动力学。
J Ocul Pharmacol Ther. 2023 Dec;39(10):735-743. doi: 10.1089/jop.2023.0035. Epub 2023 Aug 9.
4
[Ocular penetration and pharmacokinetics of topical voriconazole in rabbit eyes].[伏立康唑滴眼液在兔眼的眼内通透性及药代动力学]
Zhonghua Yan Ke Za Zhi. 2008 Apr;44(4):349-53.
5
Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.0.05% 他克莫司混悬滴眼液的制备及其局部眼部给药后的药代动力学
J Ocul Pharmacol Ther. 2009 Aug;25(4):345-50. doi: 10.1089/jop.2008.0125.
6
Determination of natamycin in rabbit cornea by high-performance liquid chromatography-tandem mass spectrometry with protective soaking extraction technology.采用保护性浸泡萃取技术结合高效液相色谱-串联质谱法测定兔角膜中的游霉素。
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 15;969:53-9. doi: 10.1016/j.jchromb.2014.08.005. Epub 2014 Aug 12.
7
Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.贝西沙星对兔、猴和人进行局部给药后的眼药代动力学。
J Ocul Pharmacol Ther. 2009 Aug;25(4):335-44. doi: 10.1089/jop.2008.0116.
8
Ocular penetration and pharmacokinetics of topical clarithromycin eye drops to rabbits.局部应用克拉霉素滴眼液对兔眼的穿透和药代动力学。
J Ocul Pharmacol Ther. 2014 Feb;30(1):42-8. doi: 10.1089/jop.2013.0042. Epub 2013 Nov 7.
9
Comparative Study of Ocular Pharmacokinetics of Gatifloxacin Between Continuous Lavage and Hourly Topical Instillation in Rabbits.加替沙星在兔眼连续灌洗与每小时局部滴注给药的眼药代动力学比较研究。
Cornea. 2018 Nov;37(11):1457-1462. doi: 10.1097/ICO.0000000000001712.
10
Ocular topotecan pharmacokinetics following topical administration to rabbits for diffused anterior retinoblastoma.将拓扑替康局部应用于兔眼治疗弥漫性前部视网膜母细胞瘤后的药代动力学。
J Pharm Pharmacol. 2017 May;69(5):574-581. doi: 10.1111/jphp.12624. Epub 2016 Aug 30.

引用本文的文献

1
Comparative efficacy of intrastromal amphotericin B versus voriconazole in treating deep-stromal refractory fungal keratitis.基质内注射两性霉素B与伏立康唑治疗深层基质难治性真菌性角膜炎的疗效比较
Indian J Ophthalmol. 2025 Jul 1;73(7):1044-1049. doi: 10.4103/IJO.IJO_2765_24. Epub 2025 Jun 30.
2
Photodynamic antimicrobial therapy with Erythrosin B, Eosin Y, and Rose Bengal for the inhibition of fungal keratitis isolates: An in vitro study.用赤藓红B、伊红Y和孟加拉玫瑰红进行光动力抗菌疗法对真菌性角膜炎分离株的抑制作用:一项体外研究。
J Photochem Photobiol B. 2025 Feb;263:113090. doi: 10.1016/j.jphotobiol.2024.113090. Epub 2024 Dec 27.
3
Clinical efficacy of cyclosporin and natamycin for fungal keratitis.
环孢素和那他霉素治疗真菌性角膜炎的临床疗效
Pak J Med Sci. 2024 May-Jun;40(5):974-978. doi: 10.12669/pjms.40.5.7777.
4
Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases.用于递送神经保护剂治疗眼部神经退行性疾病的纳米载体
Pharmaceutics. 2023 Mar 3;15(3):837. doi: 10.3390/pharmaceutics15030837.
5
Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs.日本真菌性角膜炎的多中心前瞻性观察研究:药物联合体外药敏试验分析
Jpn J Ophthalmol. 2022 May;66(3):240-253. doi: 10.1007/s10384-022-00907-2. Epub 2022 Mar 29.
6
Keratitis-Review of Current Treatment Possibilities.角膜炎——当前治疗方法综述
J Clin Med. 2021 Nov 23;10(23):5468. doi: 10.3390/jcm10235468.
7
Promising Antifungal Potential of Engineered Non-ionic Surfactant-Based Vesicles: In Vitro and In Vivo Studies.基于工程化非离子表面活性剂的囊泡具有良好的抗真菌潜力:体外和体内研究。
AAPS PharmSciTech. 2021 Jan 3;22(1):19. doi: 10.1208/s12249-020-01900-z.